论文信息 - Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth. - 字舞流文

Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.

M. F. Troncoso | G. Rabinovich | K. Mariño | S. Vanzulli | C. Wolfenstein-Todel | L. Colombo | Alejandro J. Cagnoni | F. Ferragut | Clara Sánchez Terrero | M. T. Elola | C. Wolfenstein‐Todel